Literature DB >> 19730926

[Indication for CRT].

M Schlösser1, C Stellbrink.   

Abstract

Since the first studies on cardiac resynchronization therapy (CRT), the evidence for the benefit of this electrical therapy in heart failure has continuously grown. Thus, CRT has been firmly implemented in current therapy guidelines for heart failure. However, there are distinct differences between the different guidelines published. In addition, indications for CRT are still evolving in certain patient groups. This article aims to give an overview of the current guidelines for CRT and also discusses some of the differences between the different guidelines. It also provides an outlook for potential candidates for CRT in the future where current guidelines do not yet define a clear indication for implantation of such a device.

Entities:  

Mesh:

Year:  2009        PMID: 19730926     DOI: 10.1007/s00399-009-0050-9

Source DB:  PubMed          Journal:  Herzschrittmacherther Elektrophysiol        ISSN: 0938-7412


  46 in total

1.  Comparative effects of permanent biventricular and right-univentricular pacing in heart failure patients with chronic atrial fibrillation.

Authors:  C Leclercq; S Walker; C Linde; J Clementy; A J Marshall; P Ritter; P Djiane; P Mabo; T Levy; F Gadler; C Bailleul; J-C Daubert
Journal:  Eur Heart J       Date:  2002-11       Impact factor: 29.983

2.  [Policy paper to the cardiac re-sychronization therapy].

Authors:  C Stellbrink; A Auricchio; B Lemke; W von Scheidt; J Vogt; R Dietz; M Gottwik; B Levenson; T Meinertz; A Osterpey; U Tebbe; R H Strasser; K Werdan; G Arnold; D Behrenbeck; E Fleck; H J Trappe
Journal:  Z Kardiol       Date:  2003-01

3.  Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverter-defibrillator, and mildly symptomatic chronic heart failure.

Authors:  William T Abraham; James B Young; Angel R León; Stuart Adler; Alan J Bank; Shelley A Hall; Randy Lieberman; L Bing Liem; John B O'Connell; John S Schroeder; Kevin R Wheelan
Journal:  Circulation       Date:  2004-10-25       Impact factor: 29.690

4.  Usefulness of tissue Doppler velocity and strain dyssynchrony for predicting left ventricular reverse remodeling response after cardiac resynchronization therapy.

Authors:  Cheuk-Man Yu; John Gorcsan; Gabe B Bleeker; Qing Zhang; Martin J Schalij; Matthew S Suffoletto; Jeffrey Wing-Hong Fung; David Schwartzman; Yat-Sun Chan; Masaki Tanabe; Jeroen J Bax
Journal:  Am J Cardiol       Date:  2007-08-20       Impact factor: 2.778

5.  Evaluation of left ventricular based pacing in patients with congestive heart failure and atrial fibrillation.

Authors:  Y Etienne; J Mansourati; M Gilard; V Valls-Bertault; J Boschat; D G Benditt; K G Lurie; J J Blanc
Journal:  Am J Cardiol       Date:  1999-04-01       Impact factor: 2.778

6.  Short-term effects of right-left heart sequential cardiac resynchronization in patients with heart failure, chronic atrial fibrillation, and atrioventricular nodal block.

Authors:  Ilan Hay; Vojtech Melenovsky; Barry J Fetics; Daniel P Judge; Andrew Kramer; Julio Spinelli; Craig Reister; David A Kass; Ronald D Berger
Journal:  Circulation       Date:  2004-11-22       Impact factor: 29.690

7.  Comparison of usefulness of cardiac resynchronization therapy in patients with atrial fibrillation and heart failure versus patients with sinus rhythm and heart failure.

Authors:  Peter Paul H M Delnoy; Jan Paul Ottervanger; Henk Oude Luttikhuis; Arif Elvan; Anand R Ramdat Misier; Willem P Beukema; Norbert M van Hemel
Journal:  Am J Cardiol       Date:  2007-03-13       Impact factor: 2.778

Review 8.  Selecting patients for cardiac resynchronization therapy: electrical or mechanical dyssynchrony?

Authors:  Nathaniel M Hawkins; Mark C Petrie; Michael R MacDonald; Kerry J Hogg; John J V McMurray
Journal:  Eur Heart J       Date:  2006-03-09       Impact factor: 29.983

9.  Predictors and treatment response with cardiac resynchronization therapy in patients with heart failure characterized by dyssynchrony: a pre-defined analysis from the CARE-HF trial.

Authors:  Matthew Richardson; Nick Freemantle; Melanie J Calvert; John G F Cleland; Luigi Tavazzi
Journal:  Eur Heart J       Date:  2007-05-31       Impact factor: 29.983

10.  Long-term survival in patients undergoing cardiac resynchronization therapy: the importance of performing atrio-ventricular junction ablation in patients with permanent atrial fibrillation.

Authors:  Maurizio Gasparini; Angelo Auricchio; Marco Metra; François Regoli; Cecilia Fantoni; Barbara Lamp; Antonio Curnis; Juergen Vogt; Catherine Klersy
Journal:  Eur Heart J       Date:  2008-04-04       Impact factor: 29.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.